Inovio Pharmaceuticals Current Assets

Inovio Pharmaceuticals (GBMB.F) currently reports a current assets of $40M as of June 2026. That compares with $53M in the prior-year period — down 24.3% year over year. Use the charts on this page to explore Inovio Pharmaceuticals's current assets history and peer comparisons.

Inovio Pharmaceuticals's current assets decreased from $53M to $40M — a 24.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Inovio Pharmaceuticals reported $40M in current assets as of June 2026. That compares with $53M in the prior-year period — down 24.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $40M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Inovio Pharmaceuticals, and consider following GBMB.F for alerts when major investors trade the stock.

Inovio Pharmaceuticals is classified in the Industrials sector. On current assets, it currently shows $40M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing GBMB.F with unrelated industries.